Sfoglia per AUTORE
GYAN E
Collezione ASL Biella

  

Items : 2

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. in Haematologica / Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino

Stathis A; Pirosa MC; Orsucci L; Feugier P; Tani M; Thieblemont C; Zucca E; Luminari S; Borgo E; Ielmini N; Rossi D; Cavalli F; Bertoni F; Landi F; Spina M; Re F; Pietrantuono G; Houot R; Merli M; Devizzi L; Haioun C; Liberati AM; Celli M; Pulsoni A; Angrilli F; Occhini U; Casasnovas RO; Cartron G; Cabras MG; et alii...

IELSG-38: A phase II study of chlorambucil in combination with rituximab followed by maintenance therapy with subcutaneous rituximab in patients with extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT) in Blood

2017
ASL Biella

Luminari S; Cavalli F; Zucca E; Thieblemont C; Molinari AL; Pulsoni A; Ielmini N; Cabras MG; Capochiani E; Califano C; Tilly H; Salvi F; Conconi A; Palombi F; Cavallo F; Gouill SL; Gini G; Ferrari A; Gyan E; Morschhauser F; Coiffier B; Musuraca G; Guieze R; Marino D; Stathis A; Gregorini A; Gressin R; Orsucci L; Perrot A; et alii...